62 related articles for article (PubMed ID: 20699515)
1. P16INK4A and MIB-1: an immunohistochemical expression in preneoplasia and neoplasia of the cervix.
Srivastava S
Indian J Pathol Microbiol; 2010; 53(3):518-24. PubMed ID: 20699515
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Study of p16INK4A, MIB-1 and CK17 in Pre-neoplastic and Neoplastic Epithelial Lesions of Cervix.
Sahu PD; Khandeparkar SGSKS; Joshi AR; Kulkarni MM; Gogate BP; Newadkar ND; Shinde PA; Battin SS
Gulf J Oncolog; 2022 Sep; 1(40):29-37. PubMed ID: 36448068
[TBL] [Abstract][Full Text] [Related]
3. Expression of p16INK4A in Pap smears containing atypical glandular cells from the uterine cervix.
Nieh S; Chen SF; Chu TY; Lai HC; Fu E
Acta Cytol; 2004; 48(2):173-80. PubMed ID: 15098536
[TBL] [Abstract][Full Text] [Related]
4. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
6. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
8. Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions.
Samarawardana P; Singh M; Shroyer KR
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):514-8. PubMed ID: 21602668
[TBL] [Abstract][Full Text] [Related]
9. MIB-1 and PCNA immunostaining as a diagnostic adjunct to cervical Pap smear.
Goel MM; Mehrotra A; Singh U; Gupta HP; Misra JS
Diagn Cytopathol; 2005 Jul; 33(1):15-9. PubMed ID: 15945082
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
11. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
12. The immunohistochemical detection of P16 and HPV L1 capsid protein on cell block sections from residual PapSpin liquid-based gynecology cytology specimens as a diagnostic and prognostic tool.
Haltas H; Bayrak R; Yenidunya S; Yildirim U
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1588-95. PubMed ID: 23111976
[TBL] [Abstract][Full Text] [Related]
13. p16INK4A expression in cervical premalignant and malignant lesions.
Lambert AP; Anschau F; Schmitt VM
Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
15. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
17. [Interest of new biomarkers in cervical precancerous lesion management].
Dachez R
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S152-4. PubMed ID: 18191337
[TBL] [Abstract][Full Text] [Related]
18. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
19. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
[TBL] [Abstract][Full Text] [Related]
20. [The detection of p16 protein in uterine cervix lesions].
Rotterová P; Nenutil R; Rotter L; Hanzelková Z; Dvoráková Z; Chovanec JZ; Kyclová J; Kren L
Ceska Gynekol; 2005 Jul; 70(4):295-8. PubMed ID: 16128131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]